Received: from gehenna2.rutgers.edu (gehenna2.rutgers.edu [165.230.116.135]) by csf.Colorado.EDU (8.8.8/8.8.8/ITS-4.2/csf) with SMTP id FAA15134 for ; Wed, 25 Nov 1998 05:53:29 -0700 (MST) Received: (qmail 16961 invoked by alias); 25 Nov 1998 12:52:50 -0000 Received: (qmail 16953 invoked from network); 25 Nov 1998 12:52:49 -0000 Received: from swa1.rutgers.edu (165.230.234.66) by gehenna2.rutgers.edu with SMTP; 25 Nov 1998 12:52:49 -0000 Received: by swa1.rutgers.edu with Microsoft Mail id <01BE1848.C7336A20@swa1.rutgers.edu>; Wed, 25 Nov 1998 07:54:07 -0500 Message-ID: <01BE1848.C7336A20@swa1.rutgers.edu> From: "Mark F. Schmitz" To: "'MedSoc@csf.colorado.edu'" Subject: RE: women and drug trials Date: Wed, 25 Nov 1998 07:54:06 -0500 MIME-Version: 1.0 Content-Type: multipart/mixed; boundary="---- =_NextPart_000_01BE1848.C73C91E0" ------ =_NextPart_000_01BE1848.C73C91E0 Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: 7bit The following conference announcement may be of interest. Cheers, Mark >>*** Call for submissions by November 30th 1998 *** >> >>2nd INTERNATIONAL INTERDISCIPLINARY CONFERENCE ON WOMEN & HEALTH >> >>European Association for Research on Women and Health >> >>July 12-14, 1999 >>Edinburgh Scotland >> >>This Conference aims to: >> >>. Stimulate communication and collaboration between researchers, >> clinicians and policy makers working in the area of women and >> health. >> >>. Bring critical contributions from theory and research into >> discussions of aetiology, clinical practice and health care >> systems. >> >>. Identify priority areas for women's health research. >> >>The Conference will provide a unique forum for the exchange of ideas >>and the development of new models and approaches to the understanding >>and promotion of women's health. It will appeal to psychologists, >>sociologists, doctors, nurses, midwives, psychotherapists, health care >>workers, policy makers and health advocates. >> >>The key themes of this conference are: >> >>. Addressing inequalities and human rights >> >>. Delivering appropriate health care and health services for women >> >>. Promoting women's health across cultures, ages and stages >> >>. Developing critical theories and methodologies >> >>. Lifespan perspectives >> >>We welcome submissions which are concerned with the areas of interest >>identified by the Report of the EC Commission on the state of women's >>health. These include: cardiovascular disease; incontinence; cancer; >>eating disorders; HIV/AIDS; family planning; abortion; menopause; >>violence against women; and health risk behaviours such as smoking, >>diet, exercise and alcohol consumption. >> >>For further details, abstract forms etc please see >> http://www.ucs.ed.ac.uk/~pamew/ICWH2.htm >> >>or contact the Conference Secretariat at >> conferences@bps.org.uk >> >> >>Help please! >>The difficulty with interdisciplinary conferences is in ensuring that >>information about the conference reaches the majority of potential >>participants, in their diverse disciplinary and occupational >>enclaves..... Please help by forwarding the above web address to >>anyone you know who is not on this discussion list, and who may be >>interested in the conference. Thank you. >> >> >> >>Pamela Warner >> >>Medical Statistics Unit >>Department of Public Health Sciences >>University of Edinburgh Medical School >>Teviot Place >>EDINBURGH EH8 9AG >>Scotland UK >>Ph.: 0131- 650 3248 >>Fax: 0131- 650 6909 >> -----Original Message----- From: Sue Hinze [SMTP:sxh3@po.cwru.edu] Sent: Monday, November 23, 1998 11:09 AM To: MEDICAL SOCIOLOGY Subject: women and drug trials Dear colleagues, A student e-mailed the following request; any suggestions? Thanks and please respond privately (unless you think the list would benefit): sxh3@po.cwru.edu Dear Dr. Hinze, > I am a graduate student in the Bioethics dept. I >spoke to you mid- semester about a research paper that I'm doing on the >exclusion of women from drug trials. I came upon an article which >discusses how women have been controlled to a certain extent by social >institutions. It's only about a paragraph long, but I would appreciate it >if you could direct to a few sources that might help me. The article I >have is by Vanessa Merton and is entitled, "Review Essay: Women and Health >Research". She states that, "Because social institutions are accustomed to >denying women the right to make decisions about their own welfare and that >of their offspring, it seems unremarkable for government regulators or >academic and industry scientists to decide whether a given woman, or women >as a class, can participate in a clinical trial." I am also aware of the >fact that women scientists as a group have beeen actively discriminated >against by the NIH. I'm very interested in this aspect of the exclusion of >women from drug trials. I'm particularly looking at how women have been >denied rights at an institutional level, throughout history. Please, any >sources you could direct me to would be of great help. >Thank you, >linda Susan W. Hinze, Ph.D. Assistant Professor of Sociology Case Western Reserve University 10900 Euclid Ave. Cleveland, OH 44106-7124 sxh3@po.cwru.edu ------ =_NextPart_000_01BE1848.C73C91E0 Content-Type: application/ms-tnef Content-Transfer-Encoding: base64 eJ8+IgcMAQaQCAAEAAAAAAABAAEAAQeQBgAIAAAA5AQAAAAAAADoAAEIgAcAGAAAAElQTS5NaWNy b3NvZnQgTWFpbC5Ob3RlADEIAQ2ABAACAAAAAgACAAEEkAYAwAEAAAEAAAAQAAAAAwAAMAIAAAAL AA8OAAAAAAIB/w8BAAAATQAAAAAAAACBKx+kvqMQGZ1uAN0BD1QCAAAAAE1lZFNvY0Bjc2YuY29s b3JhZG8uZWR1AFNNVFAATWVkU29jQGNzZi5jb2xvcmFkby5lZHUAAAAAHgACMAEAAAAFAAAAU01U UAAAAAAeAAMwAQAAABgAAABNZWRTb2NAY3NmLmNvbG9yYWRvLmVkdQADABUMAQAAAAMA/g8GAAAA HgABMAEAAAAaAAAAJ01lZFNvY0Bjc2YuY29sb3JhZG8uZWR1JwAAAAIBCzABAAAAHQAAAFNNVFA6 TUVEU09DQENTRi5DT0xPUkFETy5FRFUAAAAAAwAAOQAAAAALAEA6AQAAAB4A9l8BAAAAGAAAAE1l ZFNvY0Bjc2YuY29sb3JhZG8uZWR1AAIB918BAAAATQAAAAAAAACBKx+kvqMQGZ1uAN0BD1QCAAAA AE1lZFNvY0Bjc2YuY29sb3JhZG8uZWR1AFNNVFAATWVkU29jQGNzZi5jb2xvcmFkby5lZHUAAAAA AwD9XwEAAAADAP9fAAAAAAIB9g8BAAAABAAAAAAAAAJZXwEEgAEAGgAAAFJFOiB3b21lbiBhbmQg ZHJ1ZyB0cmlhbHMA6wgBBYADAA4AAADOBwsAGQAHADYABgADAD8BASCAAwAOAAAAzgcLABkABwA0 ADcAAwBuAQEJgAEAIQAAAEE1QUFEQTI2M0E4NEQyMTFCNDBBMDA2MDA4QjA3MzdEAAkHAQOQBgDo DgAAIQAAAAsAAgABAAAACwAjAAAAAAADACYAAAAAAAsAKQAAAAAAAwAuAAAAAAADADYAAAAAAEAA OQBgmWGvchi+AR4AcAABAAAAGgAAAFJFOiB3b21lbiBhbmQgZHJ1ZyB0cmlhbHMAAAACAXEAAQAA ABYAAAABvhhyr2Em2qq4hDoR0rQKAGAIsHN9AAAeAB4MAQAAAAUAAABTTVRQAAAAAB4AHwwBAAAA GQAAAG1zY2htaXR6QHJjaS5ydXRnZXJzLmVkdQAAAAADAAYQCp2YQAMABxA1DQAAHgAIEAEAAABl AAAAVEhFRk9MTE9XSU5HQ09ORkVSRU5DRUFOTk9VTkNFTUVOVE1BWUJFT0ZJTlRFUkVTVENIRUVS UyxNQVJLKioqQ0FMTEZPUlNVQk1JU1NJT05TQllOT1ZFTUJFUjMwVEgxOTk4KgAAAAACAQkQAQAA AMQLAADACwAAshQAAExaRnW4XZFzdwAKAQMB9yACpAPjAgBjgmgKwHNldDAgBxOHAoMAUA72cHJx Mg/2Jn0KgAjIIDsJbzI15jUCgAqBdWMAUAsDC2BAbmcxMDMzC6Yg0FRoZSACEGwJAAPwZRUwIAWg bmYEkAnwY3sWQABwbghgF3EHgAIwIBEAwHkgYhZAb2YgxQuAdBdBc3QuCqIKhE0KgEMWMASQcywZ tE2NCsBrGboZtD4+KhzAPCBDB0ADIAIQBcBzdbRibQQBaQIgBCBiGKA4Tm92GCAYwAXAMzAAdGgg MTk5OCAHHMEcRhxGMm5kIEkATlRFUk5BVEkKTyFwTCEURElTQ4hJUEwhIEFSWRzwBSGwRiFQRU5D RSAhIbAgV09NI4AgJkggSEUh0FRIH+5FUQhwb3BlA5FBBBBv2mMHMHQeAR1DUgeQJjDucg9wGOAD oFcDcAnwF6E1IQBIJjBsHzAf7kp1AmwYoDEyLTE0LFUfUjklZ2QLgGIIcGf1H0BTBaB0FRELMSAM FiAfBAAc8BcZB3AEIHRvOu0f7i4GACbgbSpAJtAWQO0FoG0woAMAYybUKJII4ZsLYAbgcibUGMB0 dwnhXiAZYSejGqgcoCAW8GzfC4AxcAcwBjEoknAG8DFwSxigAMBrGqEgdwWwa/8WwguALxAWMQrA JjAY4jbAvyhVNFgWMCjyGaUvukIFEL8W0gUQJuAxgAMgFwF0BRD/K/Am4gQgA1I3YgWwGKAokrsz lhkSbzRYK8AE8HUd5Z0Y8WEPwB4ACQBneSrQ/zT0O7ERQADQO4EXkiEAOWRnFvA3sTRYc3kZgBgg c/s5zzBQSQEAAjAGkBigEUB/HgA7YT1hN8E8oQWxODMn/wQgQjUzlkP/FiIuKQPwHSFbEUAekGkB ABegIDFRcTsKUB1CdTzwHVI3cmV4/w9xFTAY1AEARnAcRiiSN3K3AQAeoAkAcBgzGPFuB9HlBGJs NYRhcEqhANAWMP8vAjdjF/AEgRmAKJEWwU2q/0qhBGAm4zgGRzdFAQVASlP3UIEo4VEicEOAD3BA YgQA/nQ0OCaSVnc/ICagLyAasd9PgAhwD7BYMR3AZAPwHqDvWDFWJDdxMqBwWARCPxygjzbCGqI1 3UH5YWR2JqD/MNFD70lTNnAYoDdxB4IY8T8fMC3xFwoJcC9PMFBBZO5kGWEAkDcTZUtwB0A7cf8H kUHzS+ADkQUQLCBW0GKP/CBETtBZsTsDUINFsTDS91s5QeoPsHJK0BeARolmL/wgUFNEFtFG7QDQ A2AEEe8/YCkACHBZMmFM8DWEUfH/bxFrT2cxTsM7Gz0TZOYHgN8fMARwVnNv3zBBTAaQB5D/CrAD oCYgD6AmIEGRWcEf7r5XSjFO0DERFkAdmnct4P8n0WkyFwEXgASgCYBKQR8x/zd2P9MZJhxGSuFF UgiQIQB/HlE3cidwNeAAIGEEFkBF/kMuETEwHdQn8jdyUfEw4X9T2BxGVIYWIQ+wGRE08HX9AQA6 QpIrwB6QRnBuYQrB8z8xRmFlO4HSAiFkURdx/4PQMYB5khLgHFUmMGyzPzEHBbBRwoPQSElWL0HI SURTg9BmYR3AKlH/C1EXwBbBg9Aycibig9AYMf0mEGE/cIPAHEZK0AbwF2R+ZwtxGYA4JIhxQggF EHP+axixD4CKUVkBHYF5Ao1h/wRgNvI0RyvAD8Aq0EyQBJB/JrCBsVBDd7FWYRbyHZBt1wUwHgFf H0YFsWYIcFpy706RAZADEG7SYhmAQXIdQvsu8Q/AYzTQC1CDkmoRQtl/lj+W1wjQAEEqQDlQAkBw 0DovL3eY0C4UgF8AjQmALgDQmQBrL34KsAEHgHcvSUNXSDL6LmXwbZfhAUAqQAFAH/3/BbE74pQS N3IuKQZgBQCTQX9oUhege6eW36BvoQcXCHPUQGJWIC4FsGeZoR/u0xxGKNBscJT1IUjqK8D/ASAx cG5xGKB6ExkjPzIFIP81AQrAGKCiGRkQqTEDoAnw/x2QOwMfMJ7IC4CUUjGVBuB/PFA3YxcJN8FQ 5BYxAMBq/0XkGPE14BlARVEHQBxGCrHfO4EFIABwWCI3RGmDQmeB/4Gxp8sokiagP2AKsCbirwi3 F2ELYFnBLrRiNNBQlRTvFjClER5RHVF3goKqExeR9wbgHqB3gWJecWPDLxFNqO55AiAWQLiQdWBQ F9AH4P940FFALfEX0E9BN1It8T84/iA1ABmAbuEg8blyGISqiP8ZRHnhN0UXCIFiAHCMsLjh+5Fv H+5QmgELYCPwCsBPkPpyH+5NCYA7kzBwJtEZgPsxcAQgVQMAe6dnQK+iTxb+UB2gNgEoxSxBCJCi ghxG/8SRsTKuJSu4w2dWUQbwLVe/TrAeAAVAtNAA0ELXRSJQQE5CVVJHSH4gSHEfkDlBRxxGLFbE gEsHwRdIQIJQMDEzMS0IIDY1D+AzMjQ4iZH3YXjPKjY5MCsnHxm4CzCX8hudFPFpMzY/AUCa8kqh GUBBkBCEMTb0IC3WAk9lwagxAyDDYP8EEG8B1gMZttUUm1MLMdUWGmkqoTQBQDUAMTgw7wFADNDZ o7cwRgNhYnAMkqpiD+BTS4FIC4B6FkAAW1NNVFA6c3iIaDNANeAuY3dL0PmZQXVdGbW3MAZgAjDb NzpNAiBkGJAq0B6HMjNjKtMfkDExOtGwD/BNXd3XVC8x3sbMMUMh0VOCTyKAT0xPR1nd2P0doGp1 8ds3ODc/IEvQqiH/ByJNldgP1STUZAu2GclnQHcKwTIyJjBnClAaxhm0Qf9vgYIhGFHXQADAAxB5 4TdyfxZoCXBLcRmAi7IYoB2QZ/tvETxjPzTQvvM1gxm0lQW/GWE14FMDWbAw0SpRKBfw/4qABBG4 4mFBvyE3crtSNrHfKkB8wQnwARA7cClidRm089zO6S9EcjBQ3AM0RiEQ/xegPPA34AnAXoBkkDDh 68b9N0VCHgBzMcRSAQAFMLSh/kkcRfDxNnBRIrjiWXHPgP8PsAeBGUGrtTfgPccKsHWh+6ozIRAn PPBYYBbCfxT4Bf9MkQpAfsQ4FjzD5dn7UkKR/3fhstAxwzehO4GKgHjE+AX/PzUHkVZguVEoQ4zx FkAYwP8oYTvj6kJOQVFAN+B5oZNR/amReK6yHkImk8pmixI7cPs8VPtSdEcxDjAqUf220sH/bwBa oR9AFpCOURiwq/H4gP/zpFCCnhBoY8S3dSC4083Q//PCK8AOQZzxCBKdgE+wJpD/qeBqcv8jHcBl 4bU0d+C0ob8WIgQ2+4YGsy3xHlFWsCD/1vLJgZLQMcUt8UVCLIDJoF0q0CIncErQT6FF1wF5r4JQ KD8cVCd2IrShU39W+xGEFsFCnhCJgglleyEKaP95I8uAP2EvIHfgB+IFBouQ/nlsxzdjZcNRIjZS TpGPof8clKvWsOHtUKugd5GHgGlF/6pJfcQhkqaQdVA7ArBh/fD/lXEu8VGgnaDsYFyA4jAEgf0n Mme20XnAxbOdoOqQMMH/WKF68MJWy4BegGDAxnEV0//OIB1RPVGn4UVCVsFRIiBi/0rxeNBzMf2C +OBZsSHhd9D/sCAa8GrNRnEIMcHQbjBAsT91cq+2DpKroUDI5iMuIv8DIviiUBAIEbXxf8MASIeA /5zjnpE4NCmpLVP48I0wpSD/BrYYAnYDC6E/MoyAeECoQI+9gSfWivV85U5JSPtS//+BZ4Hx0L0e FIFGcHXifbb/AOr4BQG/Asf/ga+kgxILof/tQI4jnrEGDwcRHfh8omXE/z9idXEKSdaxioBOwRrw xuDfNGESEKviYVFYkXm0p7uS/nn7lhE1D4934VEx86Z68v/48IXBtTO0ofgFvveOdrHx399g9lrb wNcQq6BX94ZsUPVU0ES/hUF4YVHyy0FscLd1MYZRevJTV5VFxUOVMv93YP1iq6AZQmpA7PDIGPgE fjHhANowfiCNkPNQzjBBu2eAv4VDQ2MYMRrwT8ywhiDZsFKwNi03Mc/wK/Sf9a990pAAWBADABAQ AAAAAAMAERAAAAAAAwCAEP////9AAAcwALtghXIYvgFAAAgwALtghXIYvgELAACACCAGAAAAAADA AAAAAAAARgAAAAADhQAAAAAAAAMAAoAIIAYAAAAAAMAAAAAAAABGAAAAABCFAAAAAAAAAwAFgAgg BgAAAAAAwAAAAAAAAEYAAAAAUoUAALcNAAAeACWACCAGAAAAAADAAAAAAAAARgAAAABUhQAAAQAA AAQAAAA4LjAAAwAmgAggBgAAAAAAwAAAAAAAAEYAAAAAAYUAAAAAAAALAC+ACCAGAAAAAADAAAAA AAAARgAAAAAOhQAAAAAAAAMAMIAIIAYAAAAAAMAAAAAAAABGAAAAABGFAAAAAAAAAwAygAggBgAA AAAAwAAAAAAAAEYAAAAAGIUAAAAAAAAeAEGACCAGAAAAAADAAAAAAAAARgAAAAA2hQAAAQAAAAEA AAAAAAAAHgBCgAggBgAAAAAAwAAAAAAAAEYAAAAAN4UAAAEAAAABAAAAAAAAAB4AQ4AIIAYAAAAA AMAAAAAAAABGAAAAADiFAAABAAAAAQAAAAAAAAAeAD0AAQAAAAUAAABSRTogAAAAAAMADTT9NwAA dBY= ------ =_NextPart_000_01BE1848.C73C91E0--